Digital Pathology Market by 2031 – Market News, Recent Developments & Trends

The Digital Pathology Market Developments is rapidly evolving as healthcare systems increasingly embrace digital solutions to enhance diagnostic accuracy, streamline workflows, and support collaborative research. Digital pathology digitizes traditional microscopy workflows into high‑resolution, whole‑slide images that can be shared, analyzed, and integrated with advanced analytics tools. These systems are being increasingly adopted across clinical diagnostics, oncology centers, academic institutions, and pharmaceutical research to improve efficiency and patient outcomes.

According to The Insight Partners, the global digital pathology market was valued at US$ 952.62 million in 2022 and is projected to grow to US$ 1,892.40 million by 2028, at a CAGR of 12.1% during 2022–2028. The report underscores the robust momentum of digital pathology adoption driven by technological advancements and shifting clinical demand.

👉 Download sample PDF: https://www.theinsightpartners.com/sample/TIPHE100000855

Beyond this forecast period, independent market forecasts show the digital pathology market continuing its strong growth trajectory. For example, the digital pathology market is expected to reach USD 3.2 billion by 2031, expanding at a CAGR of 9.9% from 2026‑2031, supported by rising cancer incidence and the growing integration of AI and machine learning into pathology workflows.

Recent Market News & Strategic Developments

1. Expansion of Cloud‑Enabled Digital Pathology Platforms

In March 2026, Royal Philips announced an expansion of its digital pathology portfolio by launching the cloud‑enabled Philips IntelliSite Pathology Solution on HealthSuite, built in collaboration with Amazon Web Services (AWS). This development enables pathology laboratories to scale digital workflows without heavy on‑premise infrastructure, offering secure storage, collaborative access, and improved data management. This move underscores the market shift toward cloud‑native pathology solutions that simplify IT management and support broader adoption, especially in large healthcare systems.

2. Clinical Deployment Partnerships and Platform Rollouts

Labcorp, one of the largest diagnostics providers globally, expanded its partnership with PathAI in early 2026 to deploy the cloud‑based AISight Dx digital pathology platform across its national network of anatomic pathology labs. This collaboration highlights how diagnostic service providers are adopting AI‑powered platforms to enhance case management, slide review, and collaborative analysis — a significant milestone in commercializing digital pathology beyond research institutions into large clinical practice environments.

3. Funding for Next‑Generation Biomarker Platforms

Swiss biotechnology company arcoris bio secured CHF 6.3 million in seed funding to accelerate commercialization of its MUSE® biomarker detection platform designed for digital pathology applications. The investment led by Ventura Ace and ZEISS Ventures signals growing investor confidence in next‑generation diagnostic technologies that enhance biomarker sensitivity and support multiplex analysis — critical areas for advancing precision medicine.

4. Market Growth Forecasts Reflect Continued Expansion

Recent industry forecasts show that digital pathology is projected to grow rapidly in the coming decade. For instance, a DataM Intelligence report projects the global digital pathology market to reach USD 3.86 billion by 2033 at a 12.9% CAGR, with hospitals and laboratories increasingly adopting AI‑enabled diagnostic workflows and telepathology solutions.

Technology and Industry Trends Shaping the Market

AI Integration and Analytics Innovation

AI adoption remains one of the most transformative trends in digital pathology. According to broader market research, the AI in pathology market is projected to grow from USD 134.57 million in 2024 to nearly USD 1,151.55 million by 2033 at a CAGR of 27.18%, driven by demand for precision medicine, advanced image analysis, and automated interpretation.

Additionally, some vendors — including Roche Diagnostics — are integrating multiple validated AI algorithms into unified digital pathology platforms to support cancer detection, grading, and biomarker quantification, making it easier for laboratories to adopt AI‑driven tools within routine workflows.

Cloud and Collaborative Workflows

Cloud infrastructure and scalable deployment models are enabling broader adoption of digital pathology by lowering barriers to entry for smaller laboratories. Cloud‑enabled solutions facilitate remote diagnostics, secure image sharing, and collaborative case reviews across geographically dispersed healthcare systems — a trend supported by increasing telemedicine adoption.

Partnerships and Integration Efforts

Strategic collaborations between digital pathology vendors and AI developers (e.g., Indica Labs partnering with Visiopharm) reflect the industry’s focus on creating integrated ecosystems that combine imaging hardware, analytics software, and workflow management tools. These partnerships help vendors address demand for advanced analytics while improving interoperability and data management.

Top Players in the Digital Pathology Market

The competitive landscape features global technology leaders and specialized innovators investing in digital pathology platforms, AI solutions, and workflow integration:

  • Koninklijke Philips N.V. – Expanding cloud‑enabled IntelliSite solutions
  • F. Hoffmann‑La Roche Ltd. – Robust VENTANA digital pathology portfolios
  • Danaher Corporation (Leica Biosystems) – High‑resolution scanners and systems
  • Hamamatsu Photonics K.K. – Precision imaging tools
  • PathAI, Inc. – AI‑driven analysis and diagnostic platforms
  • Proscia, Inc. – Comprehensive enterprise platforms
  • Visiopharm A/S – AI and image analytics solutions
  • Indica Labs – HALO platforms for advanced image analysis
  • 3DHISTECH Ltd. – Digital slide scanning systems
  • Glencoe Software, Inc. – Visualization and workflow software

Conclusion

Recent developments in the digital pathology market — including strategic cloud deployments, expanded AI collaborations, and strong investment in diagnostic technology — signal sustained market momentum through 2031 and beyond. As clinical demand for faster, more accurate diagnostics grows, digital pathology will continue to play a central role in enabling precision medicine, remote diagnostics, and comprehensive workflow transformation across global healthcare systems.

Related Reports

1 Digital Signature Market -

2 Digital Forensics Market -

About Us:

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken form an integral part of our research methodology and makes the report unique and reliable.

Contact Us: If you have any queries about this report or if you would like further information, please contact us:

The Insight Partners

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876  

Website: www.theinsightpartners.com

Citeste mai mult